Actively Recruiting
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Led by Imperial College London · Updated on 2025-03-20
100
Participants Needed
3
Research Sites
34 weeks
Total Duration
On this page
Sponsors
I
Imperial College London
Lead Sponsor
M
Manchester University NHS Foundation Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to develop and validate a new questionnaire specifically designed to measure the health-related quality of life (HRQoL) in patients who have Chronic Pulmonary Aspergillosis (CPA). The goal is to create a tool that can be used in clinical research and trials to better understand how CPA affects patients' health status and well-being over time. The study will not involve any experimental treatments or interventions. Instead, it focuses on observing and collecting information from patients diagnosed with CPA over a period of 30 months. Participants will be asked to complete this novel questionnaire, which is tailored to capture the impact of CPA on their daily lives and overall health. Participants will be involved in providing informed consent and completing the disease-specific questionnaire during the study period. Researchers will monitor and analyze the responses to assess how CPA influences patients' quality of life. This observational study is sponsored by Imperial College London and will follow participants for up to 30 months to gather meaningful data on their health status and well-being.
CONDITIONS
Brief Title
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients 18 years old or older and able to provide informed consent
- Diagnosis of chronic pulmonary aspergillosis
- Able to speak and understand English
- Able to provide informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 months
Participants are observed over time to assess the impact of Chronic Pulmonary Aspergillosis on health status and well-being.
Trial Site Locations
Total: 3 locations
1
Ninewells Hospital & Medical School
Dundee, United Kingdom, DD1 9SY
Actively Recruiting
2
Imperial College London
London, United Kingdom
Actively Recruiting
3
Manchester NHS Foundation Trust
Manchester, United Kingdom
Actively Recruiting
Research Team
D
Dareen Marghlani, MSc
A
Anand Shah, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here